List of Hemarina patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10988730 Sand worm lyophilisate and uses thereof	Patent 10988730 was granted and assigned to Hemarina on April, 2021 by the United States Patent and Trademark Office.	Hemarina	Hemarina	United States Patent and Trademark Office	10988730	April 27, 2021
‌ US Patent 9663761 Use of annelid haemoglobin for maintaining stem cells in the undifferentiated state	Patent 9663761 was granted and assigned to Hemarina on May, 2017 by the United States Patent and Trademark Office.		Hemarina	United States Patent and Trademark Office	9663761	May 30, 2017
‌ US Patent 11224218 Heamoglobin and uses thereof	Patent 11224218 was granted and assigned to Hemarina on January, 2022 by the United States Patent and Trademark Office.		Hemarina	United States Patent and Trademark Office	11224218	January 18, 2022
‌ US Patent 10119110 Bioreactor using oxygen-carrying molecules	Patent 10119110 was granted and assigned to Hemarina on November, 2018 by the United States Patent and Trademark Office.		Hemarina	United States Patent and Trademark Office	10119110	November 6, 2018
‌ US Patent 9861095 Use of extracellular hemoglobin obtained from the marine worm,	Patent 9861095 was granted and assigned to Hemarina on January, 2018 by the United States Patent and Trademark Office.		Hemarina	United States Patent and Trademark Office	9861095	January 9, 2018
‌ US Patent 12016956 Annelid haemoglobin lyophilisation process	Patent 12016956 was granted and assigned to Hemarina on June, 2024 by the United States Patent and Trademark Office.	Hemarina	Hemarina	United States Patent and Trademark Office	12016956	June 25, 2024